Search
Medicaid Monitor
Monday, October 12, 2026 · Updated 6:12 AM MT · 40 stories today
Mon, Oct 12 · 40 stories todayPRO
← All stories
Federal PolicyOctober 10, 2026

DEA Moves to Restrict Synthetic Kratom Extract 7-OH

Federal authorities and lawmakers are increasing scrutiny of concentrated kratom extracts, including a compound known as 7-OH, sold over the counter in most states as the so-called "gas station opioid." The DEA earlier this year announced plans to temporarily ban products containing elevated concentrations of the substance, citing public health risks. The products are currently unregulated at the federal level in most jurisdictions, raising concerns about potency, labeling, and abuse potential. Increased federal attention signals possible scheduling action or new restrictions affecting product availability nationwide.

Why it mattersBehavioral health providers and state Medicaid agencies should anticipate new substance-use treatment and coverage questions if federal scheduling action restricts access to these unregulated opioid-like products.

Behavioral Health

Read the full article at thehill.com →
Also covered by:thehill.com
Share this briefing

You might also like

← All stories

Get the daily briefing.